Open
X

Posts Tagged 'LDL apheresis'

FDA Gives Premarket Approval for Modification of LDL Indications for Use of Lipoprotein Apheresis System

Posted on July 21st, 2015 · Posted in cardiology, News

by Seth J. Baum, MD, FACC, FACPM, FAHA, FNLA The FDA has granted premarket approval to Kaneka Pharma America’s application requesting approval for modification of the indications for use of.. read more